Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod

30th May 2017 Uncategorised 0

Meningococcal B vaccine Bexsero has been helping drive revenue growth for GlaxoSmithKline, but now, with a European approval, Pfizer’s Trumenba is set to challenge it in that lucrative market.

More: Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod
Source: fierce